NCT01916863View on ClinicalTrials.gov

Study to Evaluate the Effect of Single Doses of LX4211 and Canagliflozin on Intestinal Glucose Absorption in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

October 31, 2013

Conditions
Healthy Subjects
Interventions
DRUG

LX4211 400 mg

DRUG

canagliflozin 300 mg

DRUG

LX4211 Placebo

Trial Locations (1)

91911

Lexicon Investigational Site, Chula Vista

Sponsors
All Listed Sponsors
lead

Lexicon Pharmaceuticals

INDUSTRY